Search research articles
Contact Us
Filters
Showing results (1-10 of 126) with videos related to
Page
of 13
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
October 7, 2015
Conventional Therapy in Adults With XLH Improves Dental Manifestations, But Not Enthesopathy
Michael J Econs
Bone
|
October 18, 2016
Genetic diseases resulting from disordered FGF23/klotho biology
Michael J Econs
The Journal of Clinical Endocrinology and Metabolism
|
April 5, 2002
The genetics of absorptive hypercalciuria--a note of caution
Michael J Econs, Tatiana Foroud
Bone
|
February 8, 2017
Osteopetroses, emphasizing potential approaches to treatment
Anna Teti, Michael J Econs
Pediatric Endocrinology Reviews : PER
|
November 21, 2007
Fibrous dysplasia, phosphate wasting and fibroblast growth factor 23
Erik A Imel, Michael J Econs
Journal of the American Society of Nephrology : JASN
|
July 22, 2005
Fibroblast growth factor 23: roles in health and disease
Erik A Imel, Michael J Econs
The Journal of Clinical Endocrinology and Metabolism
|
March 7, 2012
Approach to the hypophosphatemic patient
Erik A Imel, Michael J Econs
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
July 4, 2006
Disease status in autosomal dominant osteopetrosis type 2 is determined by osteoclastic properties
Kang Chu, Richard Snyder, Michael J Econs
The Journal of Clinical Endocrinology and Metabolism
|
February 3, 2005
A novel GALNT3 mutation in a pseudoautosomal dominant form of tumoral calcinosis: evidence that the disorder is autosomal recessive
Shoji Ichikawa, Kenneth W Lyles, Michael J Econs
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
February 24, 2009
Genetics of familial tumoral calcinosis
Shoji Ichikawa, Erik A Imel, Michael J Econs
Page
of 13
Search research articles
Search
Showing results (1-10 of 126) with videos related to
Sort By:
Page
of 13
The Journal of Clinical Endocrinology and Metabolism
|
October 7, 2015
Conventional Therapy in Adults With XLH Improves Dental Manifestations, But Not Enthesopathy
Michael J Econs
Bone
|
October 18, 2016
Genetic diseases resulting from disordered FGF23/klotho biology
Michael J Econs
The Journal of Clinical Endocrinology and Metabolism
|
April 5, 2002
The genetics of absorptive hypercalciuria--a note of caution
Michael J Econs, Tatiana Foroud
Bone
|
February 8, 2017
Osteopetroses, emphasizing potential approaches to treatment
Anna Teti, Michael J Econs
Pediatric Endocrinology Reviews : PER
|
November 21, 2007
Fibrous dysplasia, phosphate wasting and fibroblast growth factor 23
Erik A Imel, Michael J Econs
Journal of the American Society of Nephrology : JASN
|
July 22, 2005
Fibroblast growth factor 23: roles in health and disease
Erik A Imel, Michael J Econs
The Journal of Clinical Endocrinology and Metabolism
|
March 7, 2012
Approach to the hypophosphatemic patient
Erik A Imel, Michael J Econs
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
July 4, 2006
Disease status in autosomal dominant osteopetrosis type 2 is determined by osteoclastic properties
Kang Chu, Richard Snyder, Michael J Econs
The Journal of Clinical Endocrinology and Metabolism
|
February 3, 2005
A novel GALNT3 mutation in a pseudoautosomal dominant form of tumoral calcinosis: evidence that the disorder is autosomal recessive
Shoji Ichikawa, Kenneth W Lyles, Michael J Econs
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
February 24, 2009
Genetics of familial tumoral calcinosis
Shoji Ichikawa, Erik A Imel, Michael J Econs
Page
of 13